Search

Your search keyword '"Mowat, A P"' showing total 273 results

Search Constraints

Start Over You searched for: "Mowat, A P" Remove constraint "Mowat, A P" Publication Year Range This year Remove constraint Publication Year Range: This year
273 results on '"Mowat, A P"'

Search Results

1. Identification of the DNA methylation signature of Mowat-Wilson syndrome

2. Mowat-Wilson syndrome: unraveling the complexities of diagnosis, treatment, and symptom management

3. Case Report: Novel compound heterozygous TPRKB variants cause Galloway-Mowat syndrome

4. Mowat–Wilson Syndrome: Case Report and Review of ZEB2 Gene Variant Types, Protein Defects and Molecular Interactions

6. Generation of two iPSC lines from Mowat-Wilson syndrome patients carrying heterozygous ZEB2 mutations

9. Generation of two iPSC lines from Mowat-Wilson syndrome patients carrying heterozygous ZEB2 mutations.

10. Unilateral progressive anterior iris adhesions in Mowat-Wilson syndrome: a new ocular finding.

14. The dynamin inhibitor, dynasore, prevents zoledronate-induced viability loss in human gingival fibroblasts by partially blocking zoledronate uptake and inhibiting endosomal acidification

15. Study Findings from University of Kansas Medical Center Broaden Understanding of Molecular Science (Mowat-Wilson Syndrome: Case Report and Review of ZEB2 Gene Variant Types, Protein Defects and Molecular Interactions).

16. How to find a wolverine: Factors affecting detection at wolverine (Gulo gulo) bait stations in western Canada

17. A multitiered analysis platform for genome sequencing: Design and initial findings of the Australian Genomics Cardiovascular Disorders Flagship

18. Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial

19. The executive director of the Hong Kong Tourism Board outlines what's new.

20. Virgin Atlantic: Always challenging the market.

21. Bermuda reinforces its investment in the Canadian market.

22. Children and young people's self-reported experiences of asthma and self-management nursing strategies: An integrative review.

24. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study

25. TRAVELSAVERS Canada: Bringing new solutions to market.

26. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

27. Introducing ONVIGO: a brand-new host agency group on the travel scene.

28. A look at what's new with Arts & Leisure.

29. Virtuoso tracks the trends at Canadian forum.

30. Flair seeks to make travel affordable for every Canadian.

31. Elevating the Power of Independents.

32. TRAVELSAVERS Canada: Leading with service first.

33. The renaissance of oral tolerance: merging tradition and new insights

34. Welcome to the Renaissance.

35. JUST YOU: Gaining momentum as it creates a community for solo travellers.

36. THE NEXT CHAPTERS: Canadian Travel Press launches new, web-based video series featuring 15 new Voices of Travel.

37. Voices of Travel: KEEP LISTENING TO THE VOICES OF TRAVEL.

38. Voices of Travel.

39. IT’S ALL GOING TO BE “TECH DRIVEN” Dan Langevin writes the next chapter in Voices of Travel.

40. Emergency presentation of colorectal cancer in older adults: A retrospective cohort analysis.

43. The Boat Who Wouldn’t Float.

44. Travel advisors getting 'Connected to Success' with TravelBrands.

45. Virtuoso panel taps into 2024 travel trends.

46. VOICES OF TRAVEL: THE NEXT CHAPTERS – BRUCE POON TIP’S EUREKA MOMENT.

47. DAVID HARRIS WRITES THE NEXT CHAPTER IN VOICES OF TRAVEL.

48. CELEBRATING MOMENTUM: Baxter Media launches the 24th annual Agents' Choice Readership Awards Survey.

49. Microduplications of ARID1Aand ARID1Bcause a novel clinical and epigenetic distinct BAFopathy

50. Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer

Catalog

Books, media, physical & digital resources